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ABSTRAK
Latar Belakang: IUD adalah salah satu alat kontrasepsi jangka panjang yang efektif, tetapi penggunaan di Indonesia
masih rendah. Karena inserter IUD yang biasa di pakai terlalu pendek untuk pemasangan segera pascasalin maka
bentuk inserter baru (R_inseter) telah dikembangkan.
Tujuan: Untuk mengetahui apakah R_inserter dapat digunakan dengan mudah sesuai standard pemasangan IUD
dan untuk mengetahui keamanannya.
Metode: Uji klinis fase II, post test observation.
Bahan dan cara: IUD yang dipasang adalah TCu380A dengan modifikasi pada inserternya (R_inserter) buatan PT
Kimia Farma. Penelitian ini dilakukan di 3 Rumah Sakit dan 3 Puskesmas yang merupakan afiliasi rumah sakit
pendidikan Dr Sardjito dari bulan Januari 2012 sampai April 2013. Semua klien yang memenuhi kriteria inklusi
dan eksklusi dimasukkan dalam penelitian ini. Pemasangan dilakukan oleh Residen atau Bidan yang telah
mendapatkan pelatihan. Follow up dilakukan setelah 1 minggu, 1, 3, 6, 9 dan 12 bulan pascapasang. Kemudahan,
angka ekspulsi, infeksi, nyeri, perdarahan, dan angka kelangsungan merupakan hasil utama yang diobservasi.
Hasil dan Pembahasan: Selama kurun waktu tersebut telah direkrut sebanyak 142 klien yang memenuhi kriteria
kelayakan. Lama pemasangan rata-rata adalah 3,89 ± 2,08 menit dengan minimum 2 menit dan maksimum 10
menit. Tidak ada kesulitan yang dirasakan. Secara kumulatif kejadian dalam 1, 3, 6, 9 dan 12 bulan untuk ekspulsi
masing-masing adalah 9,9%, 9,9%, 10,6%, 10,6% dan 10%. Angka ekspulsi jika IUD dipasang dalam 10 menit
pertama setelah plasenta lahir adalah 6,2% dibanding 24,1% bila pemasangan dilakukan setelah 10 menit (RR
3,90; 95%CI 1,37-11,2). Kejadian seperti infeksi, nyeri dan perdarahan relatif kecil dan dapat diatasi. Angka
kelangsungan selama 1, 3, 6, 9 dan 12 bulan berturut turut adalah 89,4%, 89,4%, 86,6% 86,6% dan 85,9%. Tidak
dijumpai kehamilan pada penelitian ini.
Kesimpulan: R_inserter dapat dipakai untuk memasang IUD CuT-380A dengan mudah dan aman. Angka kejadian
ekspulsi tertinggi terjadi dalam satu bulan pertama pascapasang dan berhubungan dengan saat pemasangan.
Kata kunci: R_inserter, IUD pascasalin, ekspulsi, infeksi, angka kelangsungan.
ABSTRACT
Background: IUD is one of the most effective and long acting contraception, but the rate of its use in Indonesia is
still low. As conventional IUD inserter is too short to deliver it during immediate postpartum (postplacental)
period, then the new inserter, R_inserter, is developped.
Objective:To find out whether the R_inserter can be used easily to deliver CuT-380A IUD during postpartum
period in a standard procedure and to find out its safety.
Method: Phase II clinical trial, post-test observation.
Materials and Method: The IUD’s used were the conventional CuT-380A with a modification on its inserter namely
9 cm longer, produced by PT Kimia Farma Indonesia. The study was carried out in three hospitals and three
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INTRODUCTION
Indonesia with237 millionpeople (2011) is now
occupying the fourth most populated country after
China (1,339,240,000), India (1,184,766,000), and
the United States (310 million).1In 2007 the number
of poor people reached 15.58% of the total
population or37.168 million.2In2010 ithas dropped
to 31.03 million, a decrease which was considered
to be slow.3 Large population with less quality is a
load of development so that the rate of population
growth must be reduced.
The use of IUD (intra-uterine device) as a
contraceptivein Indonesiaisstill relatively lowat7.2%
of all contraceptive use, smaller than the use of
injectables (58.4%), pills (24%).2 Meanwhile IUDs
meetseveral requirements such as cheap, effective,
minimal side effects, practical, and easy to deliver
provided that the service providers have been given
adequate training. Based on the 1987 Demographic
and Health Survey, the numberof births in Indonesia
reached 5.7 million per year, and 70% of them were
conducted at health facilities. Suppose 20% of
postpartum mothers were given IUD’s for her
contraceptives then the contribution of IUD for all
use of contraceptives will increase significantly.
The use of postpartum IUD (immediate post-
partum orpostplacental IUD) hasseveral advantages
such as easy on insertion, the acceptors are clearly
notbeing pregnant, it doesn’t require a specific time
tocome,andpatientsareprotectedimmediatelyafter
leaving the hospital. Nevertheless IUD shouldnot be
given without adequate counseling and informed
consentof the patient. For that purpose, counseling
of postpartum IUD insertionshould have been given
since a pregnantwomen is taking herantenatal care.
Counseling done while the patient is in labor or
deliveryoftenleadstoaregretforthedecisionis taken
in an atmosphere that is not conducive. For clients
whodonotreceiveinitialcounselingitshouldbedone
after they are free from the stress and anxiety
resulting from birth process.
IUDinsertiontechniqueshavebeenstandardized
using the “no touch and withdrawal technique”. For
CuT 380A, both arms shuld be bent andinserted into
thetubeinsidethewrapperandshouldnotabsolutely
be touched byhand although hands are using sterile
gloves. Furthermore, IUD shouldbe inserted into the
uterus through the cervical canal without touching
both the vaginal wall and the speculum. IUD is then
placed in the fundus, hold the plunger and withdraw
the tube slightly until the IUD is released. Then the
community health centers (Puskemas) which were the network of Sardjito teaching hospital, from January 2012
to April 2013. All eligible women needing IUD as their contraception were recruited. IUD insertion was carried
out by trained obstetric and gynecology resident or midwives. Follow up was done after 1 week, then 1, 3, 6, 9
and 12months after insertion.The ease of insertion, rate of the following events namely expulsion, infection,
pain, bleeding, and continuation were main outcomes of interest.
Results and Discussion: During the study period, a total 142 participants were recruited. The mean duration of
insertion was 3.89 ± 2.08 minutes (ranged 2 to 10 minutes). No subjective difficulties were perceived by the
providers. The cumulative expulsion rate for 1, 3, 6, 9 and 12 months were 9.9%, 9.9%, 10.6%, 10.6% and 10.%
consecutively. The rate of expulsion if the IUD was inserted during 10 minutes after placental delivery was 6.2%
compared to 24.1% if it was inserted after 10 minutes (RR 3.90; 95% CI 1.37-11.2). Infection, pain, and bleeding
were relatively small and could be appropriately managed. The continuation rate for 1, 3, 6, 9 and 12 months
were 89.4%, 89.4%, 86.6%, 86.6% and 85.9% consecutively. No pregnancy was found during the study period.
Conclussion: The R_inserter could be easily used to deliver a CuT-380A IUD. The rate of expulsion was highest
during the first month of insertion and was related to the time of insertion.
Keywords: R_ inserter, postpartum IUD, expulsion, infection, continuation rate.
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tube is pushed upward toward the fundus until the
IUD is placed high enough at the fundus. The tube is
pulled out until it is released from the cervix and
vagina, and the string is then cut and left about 1-2
cm from the os.
The IUD used for postpartum women so far is
using a regular IUD which is inserted in 2 ways. The
first way is by using two fingers (index and middle
fingers)where theIUD isclampedbetweenthem and
inserted into the uterine cavity through the dilated
cervix, until it is attached at the fundus. The second
one is using ring forceps in which the IUD is held at
junctionbetweenthetwohorizontalarmsandvertical
bar and it is inserted throug the dilated cervical os
and pushed deeply into the uterine fundus.4
Either way, it violates the principle of “no touch
and withdrawal technique” that could potentially
increase the risk of infection. Such procedures are
taken because conventional package of CuT-380A
IUDs available in the market is not specifically
designed for postpartum IUD insertion.
The problem is that the length of inserter of the
conventional package of CuT 380A IUD’s currently
availlable inthe market, (producedbyPTKimia Farma
Indnesia) is only 19.0 cm and it doesn’t fit the depth
ofpostpartum uterus.The principleof“no touch and
withdrawaltechnique” becomesimpossiblebecause
the entire inserter enters the vaginal cavity and no
part of the inserter could be held.
Ourpreviousstudyshowedthat themeandepht
of the uterine cavity soon after (within 10 miutes)
deliveryoftheplacentawas20cmwiththemaximum
of 28 cm. Based on that finding the new inserter (R-
inserter) was designed with the length of inserter
become 28 cm.5 No changes in the diameter of the
inserter, so that this devise is also able to be used for
interval or postabortal insertion. Using the new
R_inseter the insertion of CuT 380-A IUD became
easier and the pinciple of no touch and withdrawal
technique become possible.
OBJECTIVE OF THE STUDY.
The aim of the present study was to find out
whethertheR_insertercouldbeeasilyusedtodeliver
a postpartum IUD. It is also intended o find out the
side effects and effectiveness of IUD use such as:
expulsion, pain, bleeding, infection, removal,
continuation andpregnancy rates.
MATERIALS AND METHOD.
The IUD used in this study was the CuT 380-A
with a modified inserter on its length. It was
prolonged by9 cm to become 28 cm.As this was the
first study to try the easyness of the use of this
inserter during post placental delivery period, we
conductedafase IIclinical trial,where nocontrol was
needed. Post test observation was used.
The studywas carriedout inSardjito and2 other
2 hospitals, 3 Puskesmas that belonged to the
networking of the teaching hospital of Faculty of
Medicine Universitas Gadjah Mada Yogyakarta. It
was started from January 1912 to April 2013.
Subjects (postpartum women) meeting the
following criteria were included: all postpartum
mothersneeding IUD as theircontraceptives, vaginal
delivery, strong uterine contraction, no bleeding
during the stage IV of labor and willing to carry out
follow up visits. Pasients with signs and symptoms
of intra-labor infection (chrioamnionitis), perineal
laceration grade III to IV that tends to give rise
postpartum infectionwere excluded.
IUD insertion was carried out by obstetric and
gynecology residents of at least semester III or
midwives after adequate training using standard no
touchandwithdrawal technique.Soonafterdelivery
of theplacenta, while uterine contractionwas strong
and no bleeding was encountered, the birth
attendant changed his/her gloves. Patient was in
lithotomy position, preparation of the vulva and
vagina was carried out using 10% povidone iodine
solution.Perforatedsterile linenwasapplied.Anterior
and posterior Sims speculums were inserted. The
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anterior lip of the cervix was grasped with a ring
forceps to avoid tear. The depth of the uterine cavity
wasmeasuredbyuterine sound.The flangewas then
adjusted. As the external os of the cervix was still
dilated, the IUD was inserted without putting both
arms in to the tube and also without putting the
plunger into the tube. While the right hand of the
provider was inserting the IUD, the left hand was
placed on the abdomen at the level of the fundus.
OncethelefthandfeltthattheIUDhadbeenattaching
at the fundus, the tube was withdrawn completely,
and the IUD had been placed at the fundus. The tail
of the IUD was not cut until one or two week-follow
up.
Examination was done on follow up visits at 1
week, 1, 3, 6, 9 and 12 months. During each re-visit
the followings were done: historytaking, abdominal
palpation, in-speculoexaminationespeciallytoseethe
radix of IUD. Ultrasound examination was done in
case of doubt that IUD was not in place.The IUD was
said to be expelled if it was really recognized by the
woman, a part of or the entier UD was seen through
the external os. If the radix was not seen, then
ultrasound examination was done to make sure
whether it was still in situor it was missing.
Infection was present if there was at least three
ofthe followingfindings: elevatedbodytemperature,
pain on suprapubic or tenderness over abdominal
palpation, foul smelling lochia or purulent vaginal
discharge. Pain was a sensation complained or felt
by the acceptor thatshe neededanalgesics. Bleeding
was defined as intermenstrual bleedingormenstrual
blood flow perceived by the acceptor heavier or
longger than usual.
RESULTS AND DISCUSSION
During three months period, 142 women
meeting the eligibility criteria were recruited. The
mean age and standard deviation was 27.9 ± 5.8
years with the minimum 14 years (one participant)
and the maximum 40 years (3 participants). Most of
them were between 20 to 35 years (Table 1). In this
study, mostwomenhadonelivingchildandnonehad
more than 3 children (Table 2).
Table 1. Age of the women
Table 2. Number of living children
Ease of insertion was determined by subjective
feeling of the providers (doctors or midwives) and
thedurationoninsertion.Noneoftheprovidersfound
dificulties during insertion of these IUDs using the
new R_inserter. Duration of insertion is calculated
fromtheapplicationofthespeculumuntil the inserter
waspulledoutcompletely.Meandurationof insertion
was 3.89 minutes with the minimum of 2 minutes
(38 cases or 26.8%) and the maximum was 10
minutes (8 cases or 5.6%).
Table 3. Duration of insertion in minutes
Table 3 showed that most of insertion was
completedwithin5minutesorless.Fifteencasestook
morethan5minutesandonly8cases(5.6%) insertion
took 10 minutes. This happened at the beginning of
the study when the risidents or midwives were not
so familliarwiththetechnique.Theauthorconcluded
that insertion using R_inserter is quite simple and
easy.
Time of insertion in this study was classifed in to
two grups. The first, 113 cases (79.6%) was within
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10 minutes after delivery of the placenta (post
placental insertion)andthesecond, 29 cases (20.4%)
was within the first 48 hours after delivery
(postpartum insertion).
During the first week follow up, the most
prominent side effects found was expulsion (8.5%)
followed by pain (3.5%) and infection (0.7%). No
other side effects were encountered. At one month-
followupvisit,expulsionandpainwerestilldominant.
One case had IUD removed because of pain and
infection unresponsive to analgesic and antibiotic
treatment.
Figure 1. Cummulative events rate at one month
follow up (%). Exp, expulsion; Bld, bleeding;
Inf, infection; Rem, IUD removal.
Figure 2. Cummulative events rate at three months
follow up (%). Exp, expulsion; Bld, bleeding;
Inf, infection; Rem, IUD removal
Figure 3. Cummulative events rate at six months
follow up (%). Exp, expulsion; Bld, bleeding;
Inf, infection; Rem, IUD removal
Figure 4. Cummulative events rates at nine months
follow up (%). Exp, expulsion; Bld, bleeding;
Inf, infection; Rem, IUD removal.
Figure 5. Cummulative events rates at twelve
months follow up (%). Exp, expulsion; Bld,
bleeding; Inf, infection; Rem, IUD removal.
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The first multicentre study of postplacental IUD
was done on the late 1970s who involved 841
women, using three types of IUD: Postpartum T,
Lippes Loop D (LLD), and Coper 7-200. During 12
months observation, no uterine perforation was
reported but the pregnancy rates of Postpartum T,
LLD, and Cu7-200 were 5,6, 12,1 and 7,3 per 100
women respectively, while the expusion rates were
41, 44 and35 respectively.The studywas terminated
prematurelybythe WHObecause thepregnancyand
expusionrates exceededthe stoppingrules set in the
study protocol, namely pregnancy rate below 3 per
100 women-years and expulsion rate below 20.6
The main event in our present study was
expulsion happened during the first month after
insertion reaching 9.9% and it continued untill the
sixth months of use i.e. 10.6%. No more expulsion
was found until the end of the 12th month
observation (Fig.5). This didn’t much differ from the
study of Xu et al.6 conducted in China showing that
the one year cummulative expusion rate was 10.8%
(95% CI 8.02 -13.76) for manual insertion and 11.8%
(95% CI 8.31 – 14.24) for ring forceps insertion.
A review conducted by the WHO demonstrated
thatexpusion was a major concern because the rate
was relatively high, namely between 6% to 44.1%
during the period of 6 to 36 months of use
respectively.7 Other studies showed that immediate
postpartum IUD insertion had expulsion rate higher
than insertion during interval period. Expulsion by
six months was more likely for the immediate group
than the delayed insertion group (OR 6.77; 95% CI
1.43 to 32.14).8
The 12 months cumulative bleeding rate in this
study was 13.4% in the form of spott bledding or
menorrhagia and were perceived not to be too
annoying. This could be managed by the
administration of tranexamic acid. None asked to be
removedunless one acceptor because infectionwith
endometritis. A systematic review showed a range
between 4.6% to 12.7%.9
Talking about the association between the rate
of expulsion and time of insertion it was interesting
that number of women who underwent expusion
happened mainly when IUD was insertedbeyond 10
minutes after delivery of the placenta. The following
table showed that expulsion rate was much more
higher when IUD was inserted after 10 minutes of
the delivery of the placenta (Table 4).
Table 4. Risk of expulsion based on time of insertion
No pregnancy was observed during 12 months
follow up. Number of women who didn’t use IUD
any more had been seen since the first week of use
because of expulsion and it continued until the six
month ofobservation because of either expulsion or
they had the IUD remomed for any medical
reason.Two cases had the IUD removed because of
infection unresponsive to antibiotic treatment and
four cases due to bleeding and spotting. Nineteen
women discontinued using the IUD after 12 months
of use, consisting of 15 expulsions and 4 removals
because of medical reason giving the continuation
rate 85.9% for one year (Fig.6). A systematic review
showedthatcontinuationrateofpostpartumIUD use
ranged from 57%, 84% to 93.3%.9
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Figure 6. Continuation rate during twelve months
follow up (%).
CONCLUSION
TheR_insertercouldbeusedeasilyandsafe.The
main event was expulsion that mainly happened
during the first month after insertion. Other side
effects were infection and pain that could be
managed by antibiotic and analgesic treatment.
Bleedingwasusuallyminimal intheformofprolonged
or inter-menstrual bleedingwhich couldbe managed
by tranexamic acid. No pregnancy was observed
during one-year follow up.
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